Ticker >

Cravatex share price

Cravatex Ltd.

BSE: 509472 SECTOR: Trading  8247   12   0

450.10
-4.10 (-0.90%)
BSE: 12 Apr 04:01 PM

Price Summary

Today's High

₹ 455.25

Today's Low

₹ 440

52 Week High

₹ 686.5

52 Week Low

₹ 285

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

116.31 Cr.

Enterprise Value

112.89 Cr.

No. of Shares

0.26 Cr.

P/E

39.87

P/B

6.96

Face Value

₹ 10

Div. Yield

0.33 %

Book Value (TTM)

₹  64.63

CASH

3.43 Cr.

DEBT

0 Cr.

Promoter Holding

75 %

EPS (TTM)

₹  11.29

Sales Growth

42.48%

ROE

-96.19 %

ROCE

-87.34%

Profit Growth

-718.49 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Cravatex Ltd.

Proline Fitness Johson Horizon Matrix FILA

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year42.48%
3 Year12.88%
5 Year36.27%

Profit Growth

1 Year-718.49%
3 Year-326.96%
5 Year-329.99%

ROE%

1 Year-96.19%
3 Year-23.07%
5 Year-10.95%

ROCE %

1 Year-87.34%
3 Year-18.99%
5 Year-7.54%

Debt/Equity

0

Price to Cash Flow

-25.39

Interest Cover Ratio

-19.1630134997823

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 75 0
Sep 2023 75 0
Jun 2023 75 0
Mar 2023 75 0
Dec 2022 75 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 4.0224 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -5.42313726296078 days.
  • Company has a healthy liquidity position with current ratio of 2.31525996467245.
  • The company has a high promoter holding of 75%.

 Limitations

  • The company has shown a poor profit growth of -326.961879399402% for the Past 3 years.
  • The company has shown a poor revenue growth of 12.87872840183% for the Past 3 years.
  • Company has a poor ROE of -23.0727619218732% over the past 3 years.
  • Company has a poor ROCE of -18.9938207018854% over the past 3 years
  • Company has negative cash flow from operations of -4.581.
  • The company has a low EBITDA margin of -122.491709616738% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 0.28 0 0 0.92 0
Total Expenditure 1.1 0.69 0.54 1.53 0.62
Operating Profit -0.82 -0.69 -0.54 -0.61 -0.62
Other Income 1.06 1.19 2.45 1.27 2.41
Interest 0.16 0.68 0.08 0.08 0.13
Depreciation 0.16 0.31 0.31 0.36 0.38
Exceptional Items -32.72 0 0 0 0
Profit Before Tax -32.8 -0.48 1.52 0.22 1.28
Tax -0.44 -0.57 0.54 -0.73 0.37
Profit After Tax -32.36 0.09 0.98 0.94 0.91
Adjusted EPS (Rs) -125.22 0.35 3.78 3.64 3.52

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 1.04 2.42 2.31 2.44 3.48
Total Expenditure 3.29 5.33 4.74 4.67 6.24
Operating Profit -2.25 -2.91 -2.44 -2.23 -2.76
Other Income 7.08 7.11 10.02 8.76 9.89
Interest 1.05 0.81 0.66 0.74 1.38
Depreciation 0.83 0.85 0.74 0.7 0.81
Exceptional Items 0 0 0 0 -32.72
Profit Before Tax 2.95 2.55 6.19 5.1 -27.78
Tax 0.69 0.23 0.42 0.71 -0.64
Net Profit 2.26 2.32 5.77 4.39 -27.14
Adjusted EPS (Rs.) 8.76 8.98 22.31 16.98 -105.03

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 2.58 2.58 2.58 2.58 2.58
Total Reserves 29.26 30.49 35.98 39.59 11.68
Borrowings 4.91 3.89 3.99 4.02 0
Other N/C liabilities 4.76 4.47 5.91 4.33 1.27
Current liabilities 4.54 3.96 2.34 3.33 3.91
Total Liabilities 46.05 45.4 50.81 53.85 19.44
Assets
Net Block 2.59 1.91 2.17 1.65 2.42
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 39.86 39.54 39.37 43.13 0.42
Loans & Advances 0.22 0.22 0.44 1.44 2.58
Other N/C Assets 0 0 0 6.08 4.97
Current Assets 3.38 3.74 8.83 1.55 9.04
Total Assets 46.05 45.4 50.81 53.85 19.44
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 2.95 2.55 6.19 5.1 -27.78
Adjustment -4 -4.1 -7.14 -6.62 24.9
Changes in Assets & Liabilities -0.08 0.03 -0.4 -1.1 -1.35
Tax Paid -0.08 -0.52 -0.67 -0.6 -0.35
Operating Cash Flow -1.21 -2.04 -2.02 -3.23 -4.58
Investing Cash Flow 4.96 5.12 3.63 5.27 16.05
Financing Cash Flow -4.14 -3.77 -1.23 -1.67 -8.96
Net Cash Flow -0.39 -0.7 0.38 0.37 2.51

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 75.00 75.00 75.00 75.00 75.00
prathima batra 0.63 0.63 0.63 0.63 0.63
r b fitness and trading p... 74.36 74.36 74.36 74.36 74.36
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 25.00 25.00 25.00 25.00 25.00
investor education and pr... 1.77 1.77 1.77 1.77 1.77
mahendra girdharilal wadh... - - - 1.83 1.83
mahesh parameswaran nair 2.01 2.01 2.01 2.01 2.01
neka dipak shah 1.01 1.01 1.01 1.01 1.01
rhea dipak shah 1.01 1.01 1.01 1.01 1.01
shashank s khade 1.82 1.82 1.64 1.64 1.51

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Cravatex informs about compliance certificate5 Apr 2024, 3:46PM Cravatex - Quaterly Results14 Feb 2024, 4:43PM Cravatex - Quaterly Results14 Feb 2024, 4:43PM Cravatex informs about loss of share certificate(s)7 Nov 2023, 11:33AM Cravatex informs about loss of share certificate10 Oct 2023, 2:15PM Cravatex informs about loss of share certificate21 Sep 2023, 12:18PM Cravatex informs about book closure27 May 2023, 3:36PM Cravatex informs about PCS certificate28 Apr 2023, 1:01PM Cravatex informs about compliance certificate11 Apr 2023, 4:28PM Cravatex - Quaterly Results13 Feb 2023, 6:20PM Cravatex informs about redemption of preference shares 11 Jan 2023, 5:19PM Cravatex informs about loss of share certificate9 Dec 2022, 4:09PM Cravatex completes sale of 100% shareholding held in Cravatex Brands5 Dec 2022, 9:40AM Cravatex informs about related party transactions26 Nov 2022, 2:26PM Cravatex gets nod to sell 100% stake in Cravatex Brands20 Oct 2022, 9:46AM Cravatex informs about details of loss of certificate 4 Oct 2022, 3:17PM Cravatex informs about trading window closure29 Sep 2022, 3:05PM Cravatex informs about loss of share certificates14 Sep 2022, 9:30AM Cravatex informs about compliances-certificate8 Jul 2022, 12:44PM Cravatex informs about newspaper cutting 10 Jun 2022, 5:11PM Cravatex informs about closure of trading window29 Mar 2022, 4:11PM Cravatex informs about loss of share certificates16 Feb 2022, 12:01PM Cravatex informs about loss of share certificates16 Feb 2022, 9:59AM Cravatex informs about board meeting5 Feb 2022, 11:36AM Cravatex informs about loss of share certificates18 Dec 2021, 11:26AM Cravatex informs about board meeting1 Nov 2021, 4:13PM Cravatex informs about AGM proceedings28 Aug 2021, 11:06AM Cravatex’s arm incorporates WoS in Germany13 Feb 2021, 9:37AM Cravatex informs about board meeting4 Feb 2021, 3:44PM

Cravatex Stock Price Analysis and Quick Research Report. Is Cravatex an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Cravatex has a PE ratio of 39.8742026931254 which is high and comparatively overvalued .

  • Share Price: - The current share price of Cravatex is Rs 450.1. One can use valuation calculators of ticker to know if Cravatex share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Cravatex has ROA of -74.0664633605545 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Cravatex has a Current ratio of 2.31525996467245 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Cravatex has a ROE of -96.1868799183472 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Cravatex has a D/E ratio of 0 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Cravatex has an Inventory turnover ratio of 0 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Cravatex has reported revenue growth of 42.4841416001637 % which is fair in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Cravatex for the current financial year is -79.3083639705882 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Cravatex is Rs 1.5 and the yield is 0.3303 %.

Last Updated on:
Brief about Cravatex
X